DANIELLE MAGNESS-WELLMANN: Open Payments
NPI 1679729164 · MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$70,531 in 109 payments from 12 companies in 2025. Trend: 2023 $62,639 · 2024 $74,826 · 2025 $70,531
Speaker / faculty: $38,659Honoraria: $18,150Consulting: $7,398Travel & lodging: $4,789Food & beverage: $1,515Education: $20
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 33 | $21,713 |
| Axsome Therapeutics, Inc. | 29 | $20,962 |
| Otsuka America Pharmaceutical, Inc. | 16 | $10,890 |
| Teva Pharmaceuticals USA, Inc. | 10 | $6,742 |
| ABBVIE INC. | 9 | $5,679 |
| Biogen, Inc. | 3 | $4,368 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| Supernus Pharmaceuticals, Inc. | 2 | $40 |
| HARMONY BIOSCIENCES LLC | 1 | $34 |
| Sage Therapeutics, LLC | 1 | $18 |
Products named: CAPLYTA, Auvelity, REXULTI, AUSTEDO XR, VRAYLAR, ZURZUVAE, FANAPT, Qelbree.
Industry payments across MN — which companies pay providers there.
